News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Biotechnology Industry Organization (BIO) Commends Supreme Court for Expansive View of Patentability in Bilski Decision
June 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) released the following statement in reaction to the Supreme Court’s decision to uphold the lower court’s ruling in Bilski v. Kappos.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Biotechnology Innovation Organization (BIO)
MORE ON THIS TOPIC
FDA
US government launches AI-driven programs to overhaul clinical trials
October 1, 2026
·
4 min read
·
Gabrielle Masson
Legal
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
September 25, 2026
·
2 min read
·
Annalee Armstrong
China
China’s surging biotech sector represents both competition and lifeline for the US
September 23, 2026
·
8 min read
·
Shawna Williams
China
FDA raises bar for foreign site inspections as China trials surge
September 2, 2026
·
4 min read
·
Heather McKenzie